Alnylam Pharmaceuticals
ALNY
#649
Rank
$27.57 B
Marketcap
$224.14
Share price
-3.96%
Change (1 day)
50.78%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: $27.57 Billion

As of February 2023 Alnylam Pharmaceuticals has a market cap of $27.57 Billion. This makes Alnylam Pharmaceuticals the world's 649th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2023

End of year Market Cap

Year Market cap Change
2023$27.57 B-5.68%
2022$29.23 B44.16%
2021$20.28 B34.32%
2020$15.10 B16.87%
2019$12.92 B75.15%
2018$7.37 B-41.45%
2017$12.59 B292.16%
2016$3.21 B-59.89%
2015$8.01 B6.97%
2014$7.48 B82.71%
2013$4.09 B327.85%
2012$0.95 B175.09%
2011$0.34 B-16.59%
2010$0.41 B-43.36%
2009$0.73 B-28.02%
2008$1.02 B-13.62%
2007$1.18 B49.54%
2006$0.79 B207.77%
2005$0.25 B78.85%
2004$0.14 B

End of Day market cap according to different sources

On Feb 6th, 2023 the market cap of Alnylam Pharmaceuticals was reported to be:

$27.57 Billion
by Yahoo Finance
$27.57 Billion
by CompaniesMarketCap
$27.57 Billion
by Nasdaq
$27.56 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$183.74 B 566.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$119.42 B 333.07%๐Ÿ‡ซ๐Ÿ‡ท France
$85.03 B 208.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$10.34 B-62.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.43 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.04 B-96.22%๐Ÿ‡บ๐Ÿ‡ธ USA
$11.91 B-56.78%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$3.57 B-87.03%๐Ÿ‡บ๐Ÿ‡ธ USA